Bausch + Lomb Corporation has added to its impressive leadership ranks by bringing on Cathleen McCabe, MD, as strategic medical advisor. In this new consultancy role, she will provide input into the expansion of Bausch + Lomb’s product portfolio and lend her expertise to the research and development team as it reloads the company’s pipeline to address unmet needs. Dr. McCabe will also serve as a liaison to the expansive network of eye care professionals around the world who rely on Bausch + Lomb products and services.
“Innovation has been at the core of Cathy’s illustrious career as an ophthalmic surgeon, which aligns with our focus on providing eye care professionals, patients and consumers with new and differentiated treatment options,” said Chief Medical Officer Yehia Hashad, MD.
“Bausch + Lomb’s commitment to partnering with physicians to improve all aspects of eye care has always stood out to me,” said Dr. McCabe. “That commitment, coupled with a renewed focus on ‘what’s next’ in eye health, means big things are around the corner.”
Dr. McCabe has nearly three decades of experience as a high-volume cataract and refractive surgeon, educator and innovator. Her commitment to advancing the field of ophthalmology has led to participation in clinical trials focused on developments in intraocular lenses, perioperative medications, medications and devices to treat glaucoma, dry eye treatments and presbyopia correction.
Passionate about giving back to the community, Dr. McCabe serves as a board member for several charitable foundations including Sight for Life and the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. She has held many leadership positions in ophthalmology, including serving as president of the Outpatient Ophthalmic Surgery Society, a member of the American Academy of Ophthalmology Council, an ASCRS executive board member and as chief medical officer of Eye Health America.
Dr. McCabe received her medical degree from the Medical College of Wisconsin and completed her residency training at the Bascom Palmer Eye Institute at the University of Miami School of Medicine.
Leave a Reply